サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1664252

プロテオミクスの世界市場の評価：製品・サービス別、技術別、用途別、エンドユーザー別、地域別、機会、予測（2018年～2032年）

Proteomics Market Assessment, By Products and Services, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 236 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
プロテオミクスの世界市場の評価：製品・サービス別、技術別、用途別、エンドユーザー別、地域別、機会、予測（2018年～2032年）
出版日: 2025年02月28日
発行: Market Xcel - Markets and Data
ページ情報: 英文 236 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプロテオミクスの市場規模は、2024年の297億米ドルから2032年に762億1,000万米ドルに達すると予測され、2025年～2032年の予測期間にCAGRで12.50%の成長が見込まれます。市場の成長を支えているのは、個別化医療への要求の高まり、先進の迅速な診断ソリューションへの需要の増加、研究開発活動への注目の高まりです。質数量分析やバイオインフォマティクスなどのタンパク質分析技術の継続的な改良により、プロテオミクスの能力が強化され、臨床診断や創薬などのさまざまな分野で応用が拡大しています。

プロテオミクスプラットフォームの改良に向けた各企業の活動の高まりも、市場の拡大を後押ししています。2024年11月、タンパク質シーケンシング技術を専門とするQuantum-Si IncorporatedとNVIDIA Corporationは、前者のプロテオミクスプラットフォームであるProteusを開発し、後者の高速コンピューティング能力とAIの助けを借りてコア技術を改良するためのパートナーシップを発表しました。この提携はまた、Quantum-Siのタンパク質シーケンシングと検出技術に対する需要の高まりに対応し、データ処理速度を強化することも目的としています。投資と資金調達の増加は、疾患の早期発見を確実にするプロテオミクス技術の開発を可能にしています。2024年2月、精密プロテオミクスの主要企業の1つであるAlamar Biosciences, Inc.は、シリーズC資金調達で1億米ドルの初回クロージングを発表しました。このような資金調達により、アンメットニーズが大きい疾患に対する非侵襲的検査の開発が加速し、バイオマーカーの発見が強化されることが予測されます。

さらに、人間の健康維持に重要な役割を果たす革新的戦略の開発には、政府の取り組みも重要な役割を果たしています。2023年9月、National Institutes of Health（NIH）は、ヒトの疾患と健康に関するマルチオミクス研究に5,030万米ドルを授与しました。このような資金提供は、プロテオミクスを含むさまざまな生物学的データを統合するマルチオミクス研究を推進し、疾病の理解を深め、スケーラブルな研究戦略の開発を支援することを目的としています。

当レポートでは、世界のプロテオミクス市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のプロテオミクス市場の見通し（2018年～2032年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 地域別
    • 市場シェア分析：企業別（金額）（上位5社とその他 - 2024年）
  • 市場マップ分析（2024年）
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 地域別

第5章 北米のプロテオミクス市場の見通し（2018年～2032年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • シェア：国別
  • 各国の市場の評価
    • 米国のプロテオミクス市場の見通し（2018年～2032年）
    • カナダ
    • メキシコ

第6章 欧州のプロテオミクス市場の見通し（2018年～2032年）

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • ポーランド

第7章 アジア太平洋のプロテオミクス市場の見通し（2018年～2032年）

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第8章 南米のプロテオミクス市場の見通し（2018年～2032年）

  • ブラジル
  • アルゼンチン

第9章 中東・アフリカのプロテオミクス市場の見通し（2018年～2032年）

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ
  • イスラエル

第10章 需給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

  • 市場促進要因
  • 市場の課題

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

  • 規制当局の承認

第18章 特許情勢

第19章 ケーススタディ

第20章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Waters Corporation
    • Bruker Corporation
    • PerkinElmer AES
    • Shimadzu Corporation

第21章 戦略的提言

第22章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 3. Global Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 4. Global Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 5. Global Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Proteomics Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 9. North America Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 10. North America Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 11. North America Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Proteomics Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 15. United States Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 16. United States Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 17. United States Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 20. Canada Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 21. Canada Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 22. Canada Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 25. Mexico Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 26. Mexico Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 27. Mexico Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 30. Europe Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 31. Europe Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 32. Europe Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Proteomics Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 36. Germany Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 37. Germany Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 38. Germany Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 41. France Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 42. France Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 43. France Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 46. Italy Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 47. Italy Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 48. Italy Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 51. United Kingdom Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 52. United Kingdom Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 53. United Kingdom Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 56. Russia Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 57. Russia Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 58. Russia Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 61. Netherlands Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 62. Netherlands Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 63. Netherlands Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 66. Spain Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 67. Spain Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 68. Spain Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 71. Turkey Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 72. Turkey Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 73. Turkey Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 76. Poland Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 77. Poland Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 78. Poland Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 81. South America Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 82. South America Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 83. South America Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Proteomics Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 87. Brazil Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 88. Brazil Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 89. Brazil Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 92. Argentina Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 93. Argentina Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 94. Argentina Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 97. Asia-Pacific Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 98. Asia-Pacific Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 99. Asia-Pacific Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Proteomics Market Share (%), By Country, 2018-2032F
  • Figure 101. India Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 103. India Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 104. India Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 105. India Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 108. China Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 109. China Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 110. China Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 113. Japan Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 114. Japan Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 115. Japan Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 118. Australia Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 119. Australia Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 120. Australia Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 123. Vietnam Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 124. Vietnam Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 125. Vietnam Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 128. South Korea Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 129. South Korea Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 130. South Korea Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 133. Indonesia Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 134. Indonesia Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 135. Indonesia Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 138. Philippines Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 139. Philippines Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 140. Philippines Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 143. Middle East & Africa Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 144. Middle East & Africa Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 145. Middle East & Africa Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Proteomics Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 149. Saudi Arabia Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 150. Saudi Arabia Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 151. Saudi Arabia Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 154. UAE Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 155. UAE Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 156. UAE Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Proteomics Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Proteomics Market Share (%), By Products and Services, 2018-2032F
  • Figure 159. South Africa Proteomics Market Share (%), By Technology, 2018-2032F
  • Figure 160. South Africa Proteomics Market Share (%), By Application, 2018-2032F
  • Figure 161. South Africa Proteomics Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX12799

Global proteomics market is projected to witness a CAGR of 12.50% during the forecast period 2025-2032, growing from USD 29.70 billion in 2024 to USD 76.21 billion in 2032. The market's growth is supported by the rising requirement for personalized medicines, increasing demand for advanced and rapid diagnostic solutions, and growing emphasis on research and development activities. Continuous improvements in protein analysis technologies, such as mass spectrometry and bioinformatics, are enhancing the capabilities of proteomics, increasing its application across various fields such as clinical diagnostics and drug discovery.

Growing efforts of various companies to improve proteomics platforms are also supporting the market's expansion. In November 2024, Quantum-Si Incorporated, specializing in protein sequencing technology, and NVIDIA Corporation announced a partnership to develop the former's proteomics platform, Proteus, and improve their core technologies with the help of the latter's accelerated computing capabilities and artificial intelligence. The collaboration also aims to address the rising demand for Quantum-Si's protein sequencing and detection technology and bolster data processing speed. Rising investments and funding are allowing the development of proteomics technologies that ensure early disease detection. In February 2024, Alamar Biosciences, Inc., one of the leading precision proteomics companies, announced the first closing of USD 100 million in Series C financing. Such fundings are expected to accelerate the development of non-invasive tests for diseases with significant unmet requirements and bolster the discovery of biomarkers.

Furthermore, government initiatives are also playing a crucial role in the development of innovative strategies that play a crucial role in maintaining human health. In September 2023, the National Institutes of Health (NIH) awarded USD 50.3 million for multi-omics research on human diseases and health. Such fundings aim to advance multi-omics research, which integrates various biological data types, including proteomics, to improve the understanding of diseases and support the development of scalable research strategies.

Rising Prevalence of Infectious and Chronic Diseases Boosts Market Demand

The growing threat of various infectious and chronic diseases is boosting the global proteomics market size. As per the estimates of the National Cancer Institute (NCI), approximately 2 million cases of cancer are expected to be diagnosed in the United States in 2024. This increase is augmenting the requirement for proteomics as the field has emerged as a crucial tool for exploring the different biological changes observed in cancer. Cancer is characterized by abnormal growth of the cells, where the normal cell cycle is disrupted because of genetic factors. With the help of proteomics technology, researchers have identified important information, including signaling pathways and protein targets linked with cancer cell growth.

The rising burden of infectious diseases is also bolstering the market's demand as, over the past few years, proteomics and mass spectrometry-based technologies have been increasingly deployed for providing insights into the biological factors behind infectious diseases and characterizing the molecular details of pathogen-host relationships.

Increasing Investments Towards Proteomics Technologies Support Market Expansion

The rising investments towards advancing and accelerating the development of novel technologies in spatial proteomics and protein purification are positively influencing the expansion of the global proteomics market. In December 2024, SYNCELL, Inc., one of the leading companies in spatial proteomics analysis and next-generation subcellular protein purification, announced the closing of a USD 15 million Series A funding round to accelerate and expand the commercialization of their Microscoop platform. The pioneering platform has the ability to discover novel protein components accurately and allows unbiased, high-precision, and spatial proteomic discovery in cells and subcellular tissues.

Other factors propelling the investments in the proteomics industry include increasing emphasis on therapeutic proteins and monoclonal antibodies and rising applications of proteomics in translational research and clinical trials to accelerate the development of novel therapeutic solutions. Additionally, the growing focus of research and academic institutions in the healthcare sector to enhance patient outcomes and ensure the development of novel treatment and diagnostic options is further driving innovations in the proteomics sector.

Drug Discovery Segment Accounts for Significant Share of the Market

The rising investments in drug discovery can be attributed to the growing burden of chronic diseases and increasing investments by the pharmaceutical sector in research and development activities to address the unmet medical requirements of the patient population. Rapid innovations in various sectors, including artificial intelligence, genomics, and proteomics, are revolutionizing drug discovery, enabling precise targeting of disease mechanisms and resulting in the development of more effective and personalized therapies. Increasing collaborations between pharmaceutical and biotech companies and academic institutions foster innovation, further accelerating the drug discovery processes and bolstering the global proteomics market demand.

Additionally, various leading players in proteomics solutions are significantly investing in expanding their facilities to support the rising requirements for proteomics in the drug discovery and development sectors. In October 2024, Evosep Biosystems announced the relocation of its headquarters in Odense, Denmark. The new facility will reinforce the company's commitment to improving diagnostic and drug discovery and development processes by serving as a hub for continued innovation. The relocation is also expected to help Evosep to expand its reach in the pharmaceutical industry and align its efforts for delivering end-to-end solutions that address the evolving requirements of the biotech and pharmaceutical companies.

North America Holds Major Market Share

The rapid growth of the North American proteomics market can be attributed to the rapid expansion of the biotechnology and healthcare industries in the region, the strong presence of leading market players, increasing investments towards the development of precision medicine, and the easy availability of novel therapeutic solutions. The demand for the next generation of medicines is driven by the rising cases of age-related disorders, neurological issues, immunological diseases, infections, and cancer, among others. Furthermore, the rising cases of hereditary disorders in countries such as Canada and the United States are also bolstering the region's proteomics requirement.

Additionally, the presence of leading research institutions and their rising efforts to support advancements in proteomics research also provide lucrative growth opportunities for the market. In October 2024, the University of Arkansas for Medical Sciences (UAMS) and Thermo Fisher Scientific Inc. announced the Thermo Fisher Scientific Center of Excellence for Proteomics launch at UAMS. The first industry-academic partnership of its kind in the United States, the development of the center is expected to allow clinicians and researchers to identify unique mechanisms that are responsible for driving various human diseases, novel drug targets, and new disease biomarkers.

Future Market Scenario (2025-2032F)

As per the global proteomics market analysis, the market is expected to observe significant growth in the coming years owing to the rapid expansion of the healthcare sector and the rising requirement for novel drug launches due to the exponential growth of the population and the rising threat of various chronic diseases. According to estimates from the United Nations, the global population is expected to reach 9.7 billion by 2050.

Medical research is expected to significantly benefit from the rising utilization of proteomics, allowing the identification of new therapeutic agents and targets and supporting the development of advanced prognostic and diagnostic tests. Additionally, the emerging technologies of protein arrays and chips are expected to enhance the throughput of analytical tests in the coming years.

The convergence of advanced technologies and rising proteomics applications in biotechnology, healthcare, and pharmaceutical industries are also expected to provide lucrative growth opportunities to the market in the coming years. Moreover, strategic collaborations between pharmaceutical companies, academic institutions, and proteomic service providers will play a crucial role in addressing the unmet requirements of the clinical sector.

Key Players Landscape and Outlook

The key players in the market are actively engaging in mergers, acquisitions, and collaborations to expand their product portfolio and their presence in the proteomics market. In July 2024, Thermo Fisher Scientific Inc. announced the completion of the acquisition of Olink Holding AB, one of the leading providers of next-generation proteomics solutions. The USD 3.1 billion deal is anticipated to aid Thermo Fisher in advancing precision medicine and enhancing the understanding of human biology. Olink's proteomics solutions are complementary to Thermo Fisher's life sciences and mass spectrometry offerings and are expected to allow the latter to accelerate scientific breakthroughs and drug discovery.

The leading market players are also investing in expanding their production facilities to boost the production of different products and technologies. In June 2024, Bruker Corporation opened its production facility in Bremen, Germany. This event is a significant milestone in the company's commitment to ensure collaboration, innovation, and sustainability in the field of mass spectrometry. The facility is also expected to aid the company in meeting the growing demands for its products that are actively being adopted in various fields, including clinical proteomics, environmental analysis, and microbiology.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Proteomics Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Products and Services
      • 4.2.1.1. Instruments
      • 4.2.1.2. Reagents and Consumables
      • 4.2.1.3. Services
    • 4.2.2. By Technology
      • 4.2.2.1. Spectrometry
      • 4.2.2.2. Electrophoresis
      • 4.2.2.3. Chromatography
      • 4.2.2.4. Microarray Instruments
      • 4.2.2.5. X-Ray Crystallography
      • 4.2.2.6. Next-generation Sequencing
      • 4.2.2.7. Protein Fractionation Systems
      • 4.2.2.8. Surface Plasma Resonance (SPR) Systems
      • 4.2.2.9. Others
    • 4.2.3. By Application
      • 4.2.3.1. Drug Discovery and Development
      • 4.2.3.2. Disease Diagnosis
      • 4.2.3.3. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Academic and Research Institutes
      • 4.2.4.2. Clinical Laboratories and Hospitals
      • 4.2.4.3. Pharmaceutical and Biotechnology Companies
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Products and Services
    • 4.3.2. By Technology
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Proteomics Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Products and Services
      • 5.2.1.1. Instruments
      • 5.2.1.2. Reagents and Consumables
      • 5.2.1.3. Services
    • 5.2.2. By Technology
      • 5.2.2.1. Spectrometry
      • 5.2.2.2. Electrophoresis
      • 5.2.2.3. Chromatography
      • 5.2.2.4. Microarray Instruments
      • 5.2.2.5. X-Ray Crystallography
      • 5.2.2.6. Next-generation Sequencing
      • 5.2.2.7. Protein Fractionation Systems
      • 5.2.2.8. Surface Plasma Resonance (SPR) Systems
      • 5.2.2.9. Others
    • 5.2.3. By Application
      • 5.2.3.1. Drug Discovery and Development
      • 5.2.3.2. Disease Diagnosis
      • 5.2.3.3. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Academic and Research Institutes
      • 5.2.4.2. Clinical Laboratories and Hospitals
      • 5.2.4.3. Pharmaceutical and Biotechnology Companies
      • 5.2.4.4. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Proteomics Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Products and Services
          • 5.3.1.2.1.1. Instruments
          • 5.3.1.2.1.2. Reagents and Consumables
          • 5.3.1.2.1.3. Services
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Spectrometry
          • 5.3.1.2.2.2. Electrophoresis
          • 5.3.1.2.2.3. Chromatography
          • 5.3.1.2.2.4. Microarray Instruments
          • 5.3.1.2.2.5. X-Ray Crystallography
          • 5.3.1.2.2.6. Next-generation Sequencing
          • 5.3.1.2.2.7. Protein Fractionation Systems
          • 5.3.1.2.2.8. Surface Plasma Resonance (SPR) Systems
          • 5.3.1.2.2.9. Others
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Drug Discovery and Development
          • 5.3.1.2.3.2. Disease Diagnosis
          • 5.3.1.2.3.3. Others
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Academic and Research Institutes
          • 5.3.1.2.4.2. Clinical Laboratories and Hospitals
          • 5.3.1.2.4.3. Pharmaceutical and Biotechnology Companies
          • 5.3.1.2.4.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Proteomics Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Proteomics Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Proteomics Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Proteomics Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Thermo Fisher Scientific Inc.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 20.3.2. Danaher Corporation
    • 20.3.3. Agilent Technologies, Inc.
    • 20.3.4. Illumina, Inc.
    • 20.3.5. Bio-Rad Laboratories, Inc.
    • 20.3.6. Merck KGaA
    • 20.3.7. Waters Corporation
    • 20.3.8. Bruker Corporation
    • 20.3.9. PerkinElmer AES
    • 20.3.10. Shimadzu Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer